Target
FOXP3
7 abstracts
Abstract
Comprehensive characterization of androgen receptor expression in breast cancer.Org: Caris Life Sciences, Irving, TX, City of Hope National Medical Center, Washington University School of Medicine in St Louis, Lifespan Cancer Institute, The Warren Alpert Medical School of Brown University, Providence, RI,
Abstract
Analyses of tumor microenvironment affecting the survival in patients with ovarian cancer receiving intraperitoneal chemotherapy: Translational research from the phase 3 trial of intraperitoneal therapy for ovarian cancer with carboplatin (TRiPocc).Org: Aichi Cancer Center Research Institute, Cancer Science Institute of Singapore, National University of Singapore, Saitama Medical University International Medical Center, Hyogo Cancer Center,
Abstract
Determinants of racial disparities in immune-related adverse events (irAE) with checkpoint inhibition (ICI) in melanoma.Org: New York University School of Medicine, Laura and Isaac Perlmutter Cancer Center, NYU School of Medicine, University of Texas MD Anderson Cancer Center, NYU Grossman School of Medicine, Department of Population Health,
Abstract
TIGIT transcriptomic expression and high levels of multiple checkpoints across diverse cancers.Org: OmniSeq (Labcorp), Labcorp Oncology , OmniSeq Inc. (Labcorp), Medical College of Wisconsin and WIN Consortium,
Abstract
Immunohistochemical analysis of the tumor microenvironment in acral lentiginous melanoma (ALM).Org: USC Keck School of Medicine, Department of Medicine, Icahn School of Medicine at Mount Sinai, USC Norris Cancer Hospital, Los Angeles, CA, Department of Radiation Oncology, Sichuan Cancer Hospital & Institute, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China, Department of Pathology, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy,
Abstract
Anti–PD-1 combination regimen as first-line therapy in advanced biliary tract cancer and biomarker exploration: A retrospective study.Org: The Comprehensive Cancer Centre of Drum Tower Hospital, Clinical Cancer Institute of Nanjing University, Department of Radiology of Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Department of Pathology of Nanjing Drum Tower Hospital,
Abstract
A DMBA-induced ovarian cancer model: Could it be clinically useful to test OncoTherad and erythropoietin as anticancer approaches?Org: Laboratory of Urogenital Carcinogenesis and Immunotherapy (LCURGIM), Department of Structural and Functional Biology, Institute of Biology-University of Campinas (UNICAMP), Campinas, Brazil, Laboratory of Urogenital Carcinogenesis and Immunotherapy (LCURGIM), Institute of Biology, University of Campinas (UNICAMP), Campinas, Brazil, Laboratory of Urogenital Carcinogenesis and Immunotherapy, Institute of Biology - University of Campinas (UNICAMP), Campinas, Brazil, Laboratory of Urogenital Carcinogenesis and Immunotherapy (LCURGIM), Institute of Biology - University of Campinas – UNICAMP, Campinas, Brazil, Nanomedicine Research Unit (Nanomed), Federal University of ABC (UFABC), Santo André, Brazil, Laboratory of Urogenital Carcinogenesis and Immunotherapy (LCURGIM), Department of Structural and Functional Biology, Institute of Biology, University of Campinas (UNICAMP), Campinas, Brazil, British Columbia’s Gynecological Cancer Research (OVCARE) Program and Department of Obstetrics and Gynecology, University of British Columbia, Vancouver General Hospital, Vancouver, BC, Canada,